Literature DB >> 1371990

Detection of the ligand activity of the c-erbB-2 protein in calf serum.

R J Shan1, S Matsuda, M Ichino, T Yamamoto.   

Abstract

We established NIH3T3 derivatives in which wild-type c-erbB-2 or activated c-erbB-2 having a point mutation in the sequence coding for the transmembrane domain was expressed. These cell lines were termed RC and A4, respectively. A4 cells but not RC or NIH3T3 cells grew even in the presence of a low concentration (0.05%) of calf serum (CS), although the rate of their proliferation was low. In media containing 0.1% CS, both A4 cells and RC cells but not NIH3T3 cells could proliferate. Furthermore, RC cells induced foci formation when cultured in media containing 0.5% and 5% CS, while growth of the parental NIH3T3 cells was contact-inhibited under these conditions. These data suggest the presence of a factor(s) which activates protein-tyrosine kinase activity of the c-erbB-2 protein. In fact, the c-erbB-2 protein prepared from RC cells showed CS-dependent protein-tyrosine kinase activity when assayed in membrane fractions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371990      PMCID: PMC5918657          DOI: 10.1111/j.1349-7006.1992.tb02345.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.

Authors:  D F Stern; M P Kamps; H Cao
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

2.  Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

Authors:  R Lupu; R Colomer; G Zugmaier; J Sarup; M Shepard; D Slamon; M E Lippman
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

3.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

4.  The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.

Authors:  T Akiyama; S Matsuda; Y Namba; T Saito; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

5.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

6.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Authors:  P P Di Fiore; J H Pierce; M H Kraus; O Segatto; C R King; S A Aaronson
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

7.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

8.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

9.  Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.

Authors:  M H Kraus; N C Popescu; S C Amsbaugh; C R King
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

10.  Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.

Authors:  Y Yamada; M Yoshimoto; Y Murayama; M Ebuchi; S Mori; T Yamamoto; H Sugano; K Toyoshima
Journal:  Jpn J Cancer Res       Date:  1989-12
View more
  1 in total

1.  17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product.

Authors:  S Matsuda; Y Kadowaki; M Ichino; T Akiyama; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.